Palisade Bio Inc’s recent filing unveils that its Director Williams Donald Allen acquired Company’s shares for reported $4863.0 on May 28 ’24. In the deal valued at $4.86 per share,1,000 shares were bought. As a result of this transaction, Williams Donald Allen now holds 1,000 shares worth roughly $730.0.
Then, Finley John David bought 1,000 shares, generating $4,810 in total proceeds. Upon buying the shares at $4.81, the CEO, CFO, Director now owns 8,437 shares.
Price Performance Review of PALI
On Tuesday, Palisade Bio Inc [NASDAQ:PALI] saw its stock fall -5.06% to $0.73. Over the last five days, the stock has lost -12.54%. Palisade Bio Inc shares have fallen nearly -55.75% since the year began. Nevertheless, the stocks have fallen -89.48% over the past one year. While a 52-week high of $6.71 was reached on 01/07/25, a 52-week low of $0.60 was recorded on 04/04/25. SMA at 50 days reached $0.7595, while 200 days put it at $2.1440.
Levels Of Support And Resistance For PALI Stock
The 24-hour chart illustrates a support level at 0.5767, which if violated will result in even more drops to 0.4234. On the upside, there is a resistance level at 0.9667. A further resistance level may holdings at 1.2034. The Relative Strength Index (RSI) on the 14-day chart is 45.55, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0157, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.40%. Stochastics %K at 45.50% indicates the stock is a holding.
